Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infectious disease risks and vaccine responses in immunocompromised and diabetic travelers
NL-OMON24814Active, not recruiting
- Sponsor
- ZonMw
- Start
- Apr 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules, Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of methotrexate, azathioprine, mercaptopurine, leflunomide, infliximab and 10 more, sponsored by ZonMw. Started Apr 2009; status: active, not recruiting.
02
Drugs
methotrexateazathioprinemercaptopurineleflunomideinfliximab
Beyond the preview
Go deeper on NL-OMON24814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24814.